advertisement
 

  Back to Ask the Diabetes Team Ask the Diabetes Team
Question:

From Saylorsburg, Pennsylvania, USA:

I have read the previous responses to questions regarding saving cord blood. I am at a point where I soon must decide if we are going to invest in our daughter's future by saving the cord blood of both her aunts' babies. According to your website's advice, I infer it would be a waste of money, but I have read other seemingly well-informed positions from researchers at Harvard and Indiana State that contradict the advice given by the Diabetes Team. How do I decide what to do?

Answer:

If you can afford it, I would definitely consider saving the cord blood. Stem cells are for sure in the future, not just of diabetes treatment, but also of many other disease conditions, no matter what current President may decide in the short term about embryonic stem cell research (and there is nothing that I am aware against cord blood cells or cord blood stem cells storage). However, as you can see, there is not a unanimous position even between scientists and doctors. Therefore you should consider all options. My position is that "the sure way to fail is not to try". In this case, if you do not store these cells you'll never be able to find out whether they will be useful in the future, at least in your daughter's case.

CR

DTQ-20010724010514
Original posting 20 Aug 2001
Posted to Research: Cure

  
advertisement


                 
  Home Return to Top

Last Updated: Tuesday April 06, 2010 15:09:26
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.